Clinical Trials Browser

Phase 2 × Adrenocortical Carcinoma × apatinib × Clear all

NCT06831175 2025-06-03

Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma

Phase 2 Recruiting

Adrenal Gland Neoplasms, Adrenocortical Carcinoma

NCT04318730 2024-07-17

Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma

Phase 2 Recruiting

Adrenocortical Carcinoma